AccuStem Sciences Limited
OTC: ACMSY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Headquarters
- London, United Kingdom
- IPO year
- 2021
- Website
- https://www.accustem.com
Loading ACMSY…
Loading profile data…Frequently asked questions about ACMSY
What does AccuStem Sciences Limited (ACMSY) do?
AccuStem Sciences Limited, founded in 2020 and headquartered in London, United Kingdom, focuses on providing diagnostic assays that utilize genomic signatures. These tests are developed to forecast the probability of both short-term and long-term relapse of ER+/HER2 breast cancer in individuals with an early-stage diagnosis.
Where does ACMSY trade?
AccuStem Sciences Limited (ACMSY) trades on the Other OTC.
What sector is ACMSY in?
AccuStem Sciences Limited (ACMSY) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Where is AccuStem Sciences Limited headquartered?
AccuStem Sciences Limited is headquartered in United Kingdom.
Does ACMSY pay a dividend?
AccuStem Sciences Limited (ACMSY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACMSY go public?
AccuStem Sciences Limited (ACMSY) completed its initial public offering in 2021.